The ABC risk score for patients with atrial fibrillation - Authors' reply

Affiliations

¹ Department of Medical Sciences, Cardiology, Uppsala University, S-751 85 Uppsala, Sweden; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden. Electronic address: ziad.hijazi@ucr.uu.se.
² Department of Medical Sciences, Cardiology, Uppsala University, S-751 85 Uppsala, Sweden; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
³ Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
⁴ Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.

Comment

Ziad Hijazi et al. Lancet. 2016.

. 2016 Oct 22;388(10055):1980-1981.

doi: 10.1016/S0140-6736(16)31462-3.

¹ Department of Medical Sciences, Cardiology, Uppsala University, S-751 85 Uppsala, Sweden; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden. Electronic address: ziad.hijazi@ucr.uu.se.
² Department of Medical Sciences, Cardiology, Uppsala University, S-751 85 Uppsala, Sweden; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
³ Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
⁴ Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.

No abstract available

Comment on

The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation.
Hijazi Z, Lindbäck J, Alexander JH, Hanna M, Held C, Hylek EM, Lopes RD, Oldgren J, Siegbahn A, Stewart RA, White HD, Granger CB, Wallentin L; ARISTOTLE and STABILITY Investigators. Hijazi Z, et al. Eur Heart J. 2016 May 21;37(20):1582-90. doi: 10.1093/eurheartj/ehw054. Epub 2016 Feb 25. Eur Heart J. 2016. PMID: 26920728 Free PMC article.
The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study.
Hijazi Z, Oldgren J, Lindbäck J, Alexander JH, Connolly SJ, Eikelboom JW, Ezekowitz MD, Held C, Hylek EM, Lopes RD, Siegbahn A, Yusuf S, Granger CB, Wallentin L; ARISTOTLE and RE-LY Investigators. Hijazi Z, et al. Lancet. 2016 Jun 4;387(10035):2302-2311. doi: 10.1016/S0140-6736(16)00741-8. Epub 2016 Apr 4. Lancet. 2016. PMID: 27056738 Clinical Trial.